Skip to content
akaturk Academic measurement

Article detail · 2020 · article

Does capsaicin have therapeutic benefits in human colon adenocarcinoma? Selection of the most reliable dose via AgNOR

ISSN1303-6165
YÖKSİS OpenAlex Open access · diamond TR Index
Year2020
Citations16OpenAlex
Percentile%71.5
FWCI0.891.00 = world average
Scopus (SJR)Q3
WoS (JCR)Q4

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueTURKISH JOURNAL OF MEDICAL SCIENCES
  • Catalog match (ISSN)Turkish Journal of Medical Sciences
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)

Abstract

OpenAlex English

Background/aim: To determine the effect of different doses of capsaicin on AgNOR protein synthesis in human colon adenocarcinoma derivate from colon cancer (Caco-2 cell). Materials and methods: In this experimental study, after the cultured of Caco-2 cell line, the cells are divided into 4 groups as control and different capsaicin exposed doses (25uμ, 50uμ, and 75uμ). Mean AgNOR number and total AgNOR area/nuclear area (TAA/NA) were calculated. Results: A significant differences were detected between control and capsaicin (50uμ) (P = 0.001), between control and capsaicin (75uμ) (P = 0.000), between capsaicin (25uμ) and capsaicin (50uμ) (P = 0.001) and between capsaicin (25uμ) and capsaicin (75uμ) (P = 0.000) for TAA/NA. Also, there were significant differences between control and capsaicin (50uμ) (P = 0.001), between control and capsaicin (75uμ) (P = 0.000), between capsaicin (25uμ) and capsaicin (50uμ) (P = 0.000) and between capsaicin (25uμ) and capsaicin (75uμ) (P = 0.000) for mean AgNOR number. Conclusion: A certain amount of capsaicin has a protective effect against colon adenocarcinoma and the dose concentrations are important for the most reliable treatment.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

16citationsOpenAlex · cited_by_count (cache / database)

35 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2023 Determination of Rutins antitumoral effect on EAC solid tumor by AgNOR count and PI3K/AKT/mTOR signaling pathwayCitations 14 · OpenAlex
  2. 2023 Determination of Rutins antitumoral effect on EAC solid tumor by AgNOR count and PI3K/AKT/mTOR signaling pathwayCitations 14 · OpenAlex
  3. 2023 Determination of Rutins antitumoral effect on EAC solid tumor by AgNOR count and PI3K/AKT/mTOR signaling pathwayCitations 14 · OpenAlex
  4. 2023 Determination of Rutins antitumoral effect on EAC solid tumor by AgNOR count and PI3K/AKT/mTOR signaling pathwayCitations 14 · OpenAlex
  5. 2023 Determination of Rutin's antitumoral effect on EAC solid tumor by AgNOR count and PI3K/AKT/mTOR signaling pathwayCitations 14 · OpenAlex
  6. 2022 Expression of nucleolin, nucleophosmin, upstream binding transcription factor genes and propolis in wound modelsCitations 8 · OpenAlex
  7. 2022 Expression of nucleolin, nucleophosmin, upstream binding transcription factor genes and propolis in wound modelsCitations 8 · OpenAlex
  8. 2020 Argyrophilic nucleolar organizing regions in patients with Xeroderma Pigmentosum Group ECitations 7 · OpenAlex
  9. 2023 MDA-MB-231 Human Breast Cancer Cell Line Treated with Ginseng (Panax Quinquefolius): Evaluation by Annexin V and AgNOR StainingCitations 4 · OpenAlex
  10. 2023 MDA-MB-231 Human Breast Cancer Cell Line Treated with Ginseng (Panax Quinquefolius): Evaluation by Annexin V and AgNOR StainingCitations 4 · OpenAlex

Authors

2
  1. MUSTAFA NİSARİ NUH NACİ YAZGAN ÜNİVERSİTESİ 1
  2. RECEP ERÖZ 2